Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Passage BIO, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- −3 vs. Q1 2023
- Shares held
- 33.4M
- −2.18M (−6.1%) vs. Q1 2023
- Total value
- $31.4M
- −$2.64M (−7.8%) vs. Q1 2023
- New holders
- 8
- 9 more added
- Sold out
- 11
- 18 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $33.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.1M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 10,124,576 | $9.53M | 0.17% | +1,192,577+13.4% | Added |
| Versant Venture Management, LLC | 4,959,769 | $4.67M | 5.54% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2.35M | 2.02% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 2,160,800 | $2.03M | 0.04% | +600,000+38.4% | Added |
| BML Capital Management, LLC | 2,058,767 | $1.94M | 1.74% | +1,721,300+510.1% | Added |
| Vanguard Group Inc | 2,017,883 | $1.90M | 0.00% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1.74M | 0.10% | −1,906,915−50.8% | Reduced |
| Lynx1 Capital Management LP | 1,167,343 | $1.10M | 0.72% | −2,240,255−65.7% | Reduced |
| BlackRock Inc. | 1,055,222 | $993.3K | 0.00% | +1,223+0.1% | Added |
| Renaissance Technologies LLC | 979,095 | $922.0K | 0.00% | +14,195+1.5% | Added |
| Acadian Asset Management LLC | 578,806 | $543.0K | 0.00% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 418,173 | $393.6K | 0.23% | +418,173 | New |
| Bridgeway Capital Management, LLC | 389,600 | $366.7K | 0.01% | 00.0% | Unchanged |
| Weiss Multi-Strategy Advisers LLC | 367,696 | $346.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 331,914 | $312.4K | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 300,000 | $282.4K | 0.04% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 259,854 | $244.6K | 0.00% | −29,072−10.1% | Reduced |
| Two Sigma Advisers, LP | 247,700 | $233.2K | 0.00% | −62,800−20.2% | Reduced |
| Millennium Management LLC | 207,463 | $195.3K | 0.00% | −90,627−30.4% | Reduced |
| RBF Capital, LLC | 142,807 | $134.4K | 0.01% | +32,000+28.9% | Added |
| D. E. Shaw & Co., Inc. | 134,290 | $126.4K | 0.00% | −140,045−51.0% | Reduced |
| State Street Corp | 123,873 | $116.6K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 115,000 | $108.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 111,201 | $104.7K | 0.00% | −159,971−59.0% | Reduced |
| Pale Fire Capital SE | 98,662 | $92.9K | 0.01% | +98,662 | New |
| Citadel Advisors LLC | 86,448 | $81.4K | 0.00% | +25,470+41.8% | Added |
| Marquette Asset Management, LLC | 86,050 | $81.0K | 0.02% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 69,712 | $65.6K | 0.00% | +69,712 | New |
| FMR LLC | 62,021 | $58.4K | 0.00% | +1,400+2.3% | Added |
| Northern Trust Corp | 58,113 | $54.7K | 0.00% | −2,789−4.6% | Reduced |
| Annandale Capital, LLC | 54,338 | $51.0K | 0.01% | 00.0% | Unchanged |
| Cornercap Investment Counsel Inc | 49,767 | $46.8K | 0.01% | −51,721−51.0% | Reduced |
| HighTower Advisors, LLC | 39,323 | $30.0K | 0.00% | −8,660−18.0% | Reduced |
| Goldman Sachs Group Inc | 27,519 | $25.9K | 0.00% | −70.0% | Reduced |
| Deutsche Bank AG | 24,697 | $23.2K | 0.00% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 23,725 | $22.3K | 0.00% | +23,725 | New |
| Veritable, L.P. | 23,045 | $21.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,608 | $19.4K | 0.00% | +20,608 | New |
| Bank of New York Mellon Corp | 13,647 | $12.8K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 13,153 | $12.4K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 8,000 | $7.53K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,571 | $2.42K | 0.00% | −30,478−92.2% | Reduced |
| Federated Hermes, Inc. | 1,652 | $1.55K | 0.00% | −1,625−49.6% | Reduced |
| JPMorgan Chase & Co | 1,269 | $1.20K | 0.00% | −587,739−99.8% | Reduced |
| Royal Bank of Canada | 658 | $1.00K | 0.00% | +536+439.3% | Added |
| Steward Partners Investment Advisory, LLC | 1,010 | $951 | 0.00% | +1,010 | New |
| Rhumbline Advisers | 783 | $736 | 0.00% | +783 | New |
| US Bancorp | 500 | $471 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 244 | $230 | 0.00% | −290−54.3% | Reduced |
| Advisor Group Holdings, Inc. | 217 | $204 | 0.00% | −1,390−86.5% | Reduced |
| Clearstead Advisors, LLC | 75 | $71 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 47 | $44 | 0.00% | −53−53.0% | Reduced |
| First Capital Advisors Group, LLC. | 23 | $22 | 0.00% | +23 | New |
| Bank of America Corp | 1 | $1 | 0.00% | −33,167−100.0% | Reduced |
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −665,221−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −130,188−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −82,895−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −27,758−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −19,723−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −18,114−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,568−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,129−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −318−100.0% | Sold out |